Efficacy and safety of albumin-bound paclitaxel combined with anlotinib and immunotherapy in advanced non-small cell lung cancer with liver metastases: a retrospective study

Abstract Objective To investigate the efficacy and safety of albumin-bound paclitaxel (nab-paclitaxel) combined with anlotinib and immunotherapy as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC) and liver metastases. Methods This single-center, retrospective stud...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Hui Teng, Ni Qin, Kaiyan Liu, Cheng Gong, Jing Tang, Xiaobing Li
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2026-04-01
Schriftenreihe:	BMC Cancer
Schlagworte:	Nab-paclitaxel Anlotinib Immunotherapy Liver metastasis NSCLC
Online-Zugang:	https://doi.org/10.1186/s12885-026-15996-2
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!